ERBB2 and breast carcinoma: The 20-gene signature showed the highest signature score for the basal-like and normal subtypes of breast cancer, followed by Luminal A, while the scores for Luminal B and HER2 + breast cancer were lower in the datasets from the TCGA, METABRIC and Oslo2 breast cancer patient cohorts.